PharmaMar to Hold Fourth Quarter Financial Results Conference Call and Webcast on Friday, February 24th, 2017 Madrid, February 22, 2017 - PharmaMar (MSE:PHM), a leading biopharmaceutical company focused on the discovery and development of innovative marine-derived anticancer drugs, today announced that it will release Fourth Quarter and Year-End 2017 financial results on Thursday, February 23, 2017. Further, PharmaMar management will host an investment-community conference call at 8:00 a.m. ET on Friday February 24, 2017 to discuss the financial results and to provide a corporate update.

Investors who wish to participate in the conference call may do so by dialing 877-407- 3102 for U.S. and Canadian callers or 201-493-6790 for international callers. Those interested in listening to the conference call live via the internet may do so by visiting the Events Calendar page of the company's website at www.pharmamar.com and clicking on the webcast link.

A webcast replay will be available on the PharmaMar website for 30 days following the call by visiting the Events Calendar page of the company's website at www.pharmamar.com.

About PharmaMar

Headquartered in Madrid, PharmaMar is a world-leading biopharmaceutical company in the discovery and development of innovative marine-derived anticancer drugs. The company has an important pipeline of drug candidates and a robust R&D oncology program. PharmaMar develops and commercializes YONDELIS® in Europe and has three other clinical-stage programs under development for several types of solid and hematological cancers, PM1183, plitidepsin, and PM184. PharmaMar is a global biopharmaceutical company with subsidiaries in Germany, Italy, France, Switzerland, United Kingdom, Belgium and the United States. PharmaMar fully owns other companies: GENOMICA, Spain's leading molecular diagnostics company; Sylentis, dedicated to researching therapeutic applications of gene silencing (RNAi); and two other chemical enterprises, Zelnova Zeltia and Xylazel. To learn more about PharmaMar, please visit us at www.pharmamar.com.

Disclaimer

This document is a press release, not a prospectus. This document does not constitute or form part of an offering or invitation to sell or a solicitation to purchase, offer or subscribe shares of the company. Moreover, no reliance should be placed upon this document for any investment decision or contract and it does not constitute a recommendation of any type with regard to the shares of the company.

Media Contact:

Alfonso Ortín - Communications Director aortin@pharmamar.com Mobile: + 34609493127

Paula Fernández - Media Relations Manager pfalarcon@pharmamar.com Mobile: +34 638796215 Phone: +34 918466000

Investor Relations:

Phone: +34 914444500

Or please visit our website at www.pharmamar.com

###

Pharma Mar SA published this content on 22 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 February 2017 09:51:06 UTC.

Original documenthttps://www.pharmamar.com/2017/02/22/pharmamar-to-hold-fourth-quarter-financial-results-conference-call-and-webcast-on-friday-february-24th-2017/

Public permalinkhttp://www.publicnow.com/view/7BFD3448A681946CDC6CE225BB5C958E6337EAC7